-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $150

Benzinga·10/02/2026 13:05:39
Listen to the news
Guggenheim analyst Seamus Fernandez maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $88 to $150.